References
- Jankovic J. Tourette syndrome: phenomenology and classification of tics. Neurol Clin 1997; 15(2): 267–75
- Dodick D, Adler CH. Tourette's syndrome: current approaches to recognition and management. Postgrad Med 1992; 92(5): 299–308
- Karp BI, Hallett M. Extracorporeal ‘phantom’ tics in Tourette's syndrome. Neurology 1996; 46(l): 38–40
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Assn, 1994: 103
- Bagheri MM, Kerbeshian J, Burd L. Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician 1999; 59(8): 2263–72
- Kurlan R. Tourette's syndrome and ‘PANDAS’: Will the relation bear out? Pediatric autoimmune neuropsychiatrie disorders associated with streptococcal infection. Neurology 1998; 50(6): 1530–4
- Muller-Vahl KR, Kolbe H, Schneider U, et al. Cannabis in movement disorders. Forsch Komplementarmed 1999; 6 Suppl 3: 23–7
- Hanna PA, Janjua FN, Contant CF, et al. Bilineal transmission in Tourette syndrome. Neurology 1999; 53(4): 813–8
- Alsobrook JP 2d, Pauls DL. The genetics of Tourette syndrome. Neurol Clin 1997; 15(2): 381–93
- A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. Am J Hum Genet 1999; 65(5): 1428–36
- Leckman JF, Peterson BS, Pauls DL, et al. Tic disorders. Psychiatr Clin North Am 1997; 20(4): 838–61
- Dursun SM, Reveley MA, Bird R, et al. Longlasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 1994; 344(8936): 1577
- Sheppard DM, Bradshaw JL, Purcell R, et al. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clin Psychol Rev 1999; 19(5): 531–52
- Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 1997; 6: S129–45
- Lipinski JF, Sallee FR, Jackson C, et al. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 1997; 12(3): 402–7
- Jankovic J. Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol 1993; 50(3): 286–8
- Popper CW. Antidepressants in the treatment of attention- deficit/hyperactivity disorder. J Clin Psychiatry 1997; 58 Suppl 14: 14–29
- Vandewalle V, van der Linden C, Groenewegen HJ, et al. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 1999; 353(9154): 724